A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 164 participants.
Also called NCT03350347
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 164 participants
- Sponsor
- Registry
-
NCT03350347
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT03350347. Randomized; no masking; primary purpose treatment. Start 2017-12-13 (actual); primary completion 2019-07-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects
- Acronym
- MIYABI ND-M
- Condition
- Anemia
- Condition
- Renal Insufficiency, Chronic
- Intervention (Drug)
- Molidustat (BAY85-3934)
- Intervention (Drug)
- Darbepoetin alfa
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct03350347- Content hash
2d37088cbb93a5dd1c8db75f0e5449fc9738a99ad4c411c260e46e4771620328